## Abstract Three patients with external small bowel fistulas were successfully treated with bowel rest, total parenteral nutrition, and the somatostatin analog, octreotide. Two of the patients had received prior multimodality therapy, including radiation, for gynecologic cancer. The time intervals
Somatostatin analog treatment of a cervical thoracic duct fistula
✍ Scribed by Carl N. Valentine; Roberto Barresi; Richard A. Prinz
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 63 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Reoperation for recurrent thyroid cancer poses an increased risk of complications, including thoracic duct fistula. Treatment of this complication is controversial. A survey of thoracic literature reports the use of somatostatin analog, whereas no cases have reported the use of this therapy in cases arising from neck dissection.
Methods
We report a 16‐year‐old girl with recurrent papillary thyroid cancer who had a persistent lymphatic‐cutaneous fistula develop after repeat modified left neck dissection. Despite conservative management, drainage persisted for 2 months. A regimen was begun that included TPN and injections of a somatostatin analog.
Results
Treatment with a somatostatin analog resulted in an immediate attenuation of drainage and subsequent closure of the fistula after 16 days of treatment.
Conclusion
The use of somatostatin analog can increase the success of conservative management of thoracic duct fistulae. © 2002 Wiley Periodicals, Inc. Head Neck 24: 810–813, 2002
📜 SIMILAR VOLUMES
## Abstract ## Background. Chylous fistula occurring after head and neck or thoracic surgery is an uncommon but well‐described complication, with a reported incidence of 1% to 2.5%. Conservative management can be successful and consists of dietary measures combined with suction drainage. This arti